Effectiveness of Superficial Cervical and Clavipectoral Block for Clavicle Surgery
BSS-BKvsBSS-BI
The Effectiveness of the Combination of Superficial Cervical Block With Clavipectoral Block Compared to the Combination With Interscalene Block in Clavicle Fracture Surgery
2 other identifiers
interventional
34
1 country
1
Brief Summary
This study aims to compare two local anesthesia techniques (nerve blocks) for patients undergoing collarbone (clavicle) fracture surgery. Typically, this surgery uses the "Interscalene Block" (ISB) technique. However, this method carries risks of side effects such as shortness of breath because the nerves controlling the respiratory muscles may also be numbed. As an alternative, researchers want to test a newer combination: the "Clavipectoral Block" (CPB) combined with the "Superficial Cervical Block" (SCB). The researchers want to determine if the new combination (SCB-CPB) provides pain relief as effective as the traditional technique (SCB-ISB), but with improved safety, particularly in maintaining the patient's respiratory stability and heart rate. During the study, patients will be randomly assigned to one of two groups: SCB-CPB Group: Receives a combination of nerve blocks in the collarbone area. SCB-ISB Group: Receives a combination of nerve blocks in the neck area (interscalene). The results of this study are expected to provide a more comfortable and safer anesthesia option for patients undergoing clavicle surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2026
CompletedStudy Start
First participant enrolled
April 16, 2026
CompletedFirst Posted
Study publicly available on registry
April 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 16, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
April 23, 2026
April 1, 2026
3 months
April 15, 2026
April 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Duration of Analgesia
the primary objective is to evaluate and compare the total duration of effective analgesia provided by the two regional anesthesia techniques. This is defined as the time interval from the successful completion of the nerve block (confirmed by loss of sensation in the surgical area) until the patient first requests rescue analgesia or reports a pain intensity score of \>3 on the Visual Analog Scale (VAS). A longer duration indicates a more effective and stable block for postoperative pain management
Up to 24 hours postoperatively.
Secondary Outcomes (5)
Time Taken to Perform Nerve Blocks
During the preoperative phase (at the time of the procedure).
Time to Onset of Sensory Block
Within 30 minutes after the nerve block procedure.
Mean Arterial Pressure (MAP)
From the time of nerve block administration (T1) through the end of the surgery and into the immediate postoperative recovery period (up to approximately 3 hours)
Heart Rate (HR)
From the time of nerve block administration (T1) through the end of the surgery and into the immediate postoperative recovery period (up to approximately 3 hours)
Incidence of Partial or Incomplete Sensory Blockade
From 30 minutes post-block administration until the completion of the surgical procedure.
Study Arms (2)
SCB + CPB Group
EXPERIMENTALThis group consists of participants undergoing surgical fixation for clavicle fractures who are assigned to receive a regional anesthesia combination targeting the local anatomy of the collarbone. This arm specifically evaluates the efficacy of blocking the sensory nerves without involving the deeper brachial plexus structures
SCB + ISB Group
ACTIVE COMPARATORThis group serves as the active control, representing the conventional regional anesthesia approach for clavicle and shoulder procedures. Participants in this arm receive the standard nerve block combination to provide a baseline for comparing pain relief and safety profiles
Interventions
The experimental intervention involves a specialized regional technique aimed at providing targeted anesthesia while minimizing motor weakness in the arm. The procedure begins with the patient in a supine position and the head turned to the opposite side. Under ultrasound guidance using a high-frequency linear probe, the physician identifies the clavipectoral fascia and the periosteum of the clavicle. After local skin infiltration with lidocaine, a block needle is inserted using an in-plane approach into the space between the pectoralis major muscle and the clavicular periosteum. A volume of 20 mL of an anesthetic mixture consisting of 0.25% Bupivacaine and 1% Lidocaine is injected both superiorly and inferiorly to the clavicle to surround the bone with anesthesia. Following this, the Superficial Cervical Block is performed by injecting an additional 10 mL of the same mixture at the posterior border of the sternocleidomastoid muscle. This approach is specifically chosen to provide sens
The control intervention utilizes the standard interscalene approach, which is a well-established technique for shoulder and upper extremity surgery. With the patient positioned similarly and under ultrasound guidance, the practitioner identifies the interscalene groove located between the anterior and middle scalene muscles. The nerve roots of the brachial plexus, typically C5 and C6, are visualized as a "cluster of grapes" appearance. After skin infiltration, the needle is advanced until the tip is adjacent to these nerve roots, and 20 mL of the anesthetic mixture (0.25% Bupivacaine and 1% Lidocaine) is administered. To complete the sensory coverage required for the skin incision over the clavicle, a Superficial Cervical Block is also performed using 10 mL of the mixture at the lateral aspect of the sternocleidomastoid muscle. While this technique provides dense and reliable anesthesia for the surgical site, it inherently carries a higher risk of motor blockade in the upper limb and
Eligibility Criteria
You may qualify if:
- Surgical Requirement: Patients scheduled to undergo elective or emergency surgery for clavicle fracture fixation (Open Reduction Internal Fixation).
- Physical Status: Patients classified as American Society of Anesthesiologists (ASA) Physical Status I or II (healthy patients or those with mild systemic disease).
- Age Range: Adult patients aged between 20 and 60 years.
- Body Mass Index (BMI): Patients with a BMI within the range of 18.5 to 30kg/m2.
- Cognitive Status: Patients who are conscious, cooperative, and able to communicate effectively to provide informed consent and report pain scores (VAS).
- Consent: Patients who have voluntarily signed the written informed consent form after a full explanation of the procedure.
You may not qualify if:
- Hypersensitivity or known allergy to local anesthetics. Patients presenting with respiratory compromise or significant pulmonary dysfunction.
- Clinical history of coagulopathy or blood coagulation disorders.
- Active infection at the site of needle insertion/puncture.
- Chronic opioid consumption, defined as continuous use for three consecutive months.
- Refusal to provide informed consent or participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ngoerah Hospital
Denpasar, Bali, 80114, Indonesia
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
I Gusti Ngurah M Arimbawa, MD, PhD, Sp.An, Subsp.An.R,FIP
Udayana University
- STUDY CHAIR
Pontisomaya Parami, MD, PhD, Sp.An,FCC
Udayana University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The study is conducted as a double-blind trial to ensure the objectivity of the clinical findings. While the anesthesiologist performing the nerve blocks is aware of the group assignment due to the nature of the procedural intervention, they are not involved in any subsequent data collection or outcome assessment. To maintain blinding for the participants, they are informed only that they will receive one of two regional anesthesia combinations without being told which specific technique is administered. Furthermore, the researchers acting as outcomes assessors, who evaluate critical parameters such as hemodynamic stability, pain scores, and the duration of analgesia-remain masked to the treatment allocation until the study is completed and the data is analyzed
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor in an Anesthesiology and Intensive Therapy Specialist Program
Study Record Dates
First Submitted
April 15, 2026
First Posted
April 23, 2026
Study Start
April 16, 2026
Primary Completion (Estimated)
July 16, 2026
Study Completion (Estimated)
July 30, 2026
Last Updated
April 23, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to ensure the privacy and confidentiality of the study participants in accordance with institutional ethics committee policies. However, the study protocol and the final analyzed results (aggregated data) will be available through the final research report or publication.